The effects of the early administration of sivelestat sodium, a selective neutrophil elastase inhibitor, on the postoperative course after radical surgery for esophageal cancer

Surgery Today

Volumn 42, Issue 7, 2012, Pages 659-665

  Nishiyama, Junichi ^a   Matsuda, Mitsumasa ^a   Ando, Satoko ^a   Hirasawa, Miyoko ^a   Suzuki, Toshiyasu ^a   Makuuchi, Hiroyasu ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Esophageal cancer; Inflammatory reaction; Radical surgery; Respiratory function; Sivelestat

Indexed keywords

C REACTIVE PROTEIN; SIVELESTAT;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; ESOPHAGUS CANCER; FEMALE; HEALTH CARE COST; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OXYGEN SATURATION; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFLAMMATION; POSTOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT RESPONSE;

ACUTE LUNG INJURY; AGED; C-REACTIVE PROTEIN; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; GLYCINE; HUMANS; INFLAMMATION; LENGTH OF STAY; MALE; MIDDLE AGED; OXYGEN; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATIONS; PROTEINASE INHIBITORY PROTEINS, SECRETORY; RETROSPECTIVE STUDIES; SULFONAMIDES; SURVIVAL RATE;

EID: 84863987039     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-011-0105-5     Document Type: Article

References (31)

1. Nakae H, Endo S, Inada K, Kasai T, Yoshida M. Significance of a-tocopherol and interleukin 8 in septic adult respiratory distress syndrome. Res Commun Chem Pathol Pharmacol. 1994;84: 197-202.
2. Endo S, Inada K, Inoue Y, Kuwata Y, Suzuki M, Yamashita H, et al. Two types of septic shock classified by the plasma levels of cytokines and endotoxin. Circ Shock. 1992;38:264-74.
3. Endo S, Inada K, Yamada Y, Kasai T, Takakuwa T, Nakae H, et al. Plasma tumor necrosis factor-a (TNF-a) levels in patients with burns. Burns. 1993;19:124-7. (Pubitemid 23131875)
4. Endo S, Inada K, Yamashita H, Takakuwa T, Nakae H, Kasai T, et al. Platelet activating factor (PAF) acetylhydrolase activity type II phosholipase A2, and cytokine levels in patients with sepsis. Res Commun Chem Pathol Pharmacol. 1994;83:289-95.
5. Endo S, Inada K, Ceska M, Takakuwa T, Yamada Y, Nakae H, et al. Plasma interleukin 8 and polymorphonuclear leukocyte elastase concentrations in patients with septic shock. J Inflammation. 1995;45:136-42.
6. Tanaka T, Sugimoto H, Yoshikawa T, Sugimoto T. Role of granulocyte elastase in tissue injury in patients with septic shock complicated by multiple-organ failure. Ann Surg. 1991;213:81-5.
7. Petty TL. Protease mechanisms in the pathogenesis of acute lung injury. Ann NY Acad Sci. 1991;624:267-77.
8. Yachida S, Wakabayashi H, Kokudo Y, Goda F, Okada S, Maeba T, et al. Measurement of serum hyaluronate as a predictor of human liver failure after major hepatectomy. World J Surg. 2000; 24:359-64. (Pubitemid 30117767)
9. Committee for Preparation of ARDS Guidelines of the Japanese Respiratory Society. Guidelines for Treatment of ALI/ARDS, Tokyo: Shujunsha; 2005.
10. Hyoba R, Satomi S. Changes in cytokines after surgery for esophageal cancer. Rinshogeka (Jpn J Clin Surg). 1997;52:583-9. (in Japanese).
11. Sakamoto K, Arakawa H, Mita S, Ishiko T, Ikei S, Egami H, et al. Elevation of circulating interleukin 6 after surgery: factors influencing the serum level. Cytokine. 1994;6:181-6. (Pubitemid 24263857)
12. Sato N, Hida K, Ikeda K, Oysuka K, Kimura Y, Aoki K, et al. Effect of preoperative methylprednisolone on esophageal surgical stress. Nihon Syokakigeka Gakkaizasshi (Jpn J Gastroenterol Surg). 1997;30889:1831-8. (in Japanese).
13. Yoshida K, Nishihira T, Hyoba R, Nakano T, Akaishi T, Hirayama K, et al. Administration experience of urinastatin in cases ofoperation of thoracic esophagus cancer cases. Renal function and granulocytic elastase. Rinshotokenkyu (Jpn J Clin Exp Med) 1990;67: 2601-04 (in Japanese).
14. Ono S, Aosasa S, Mochizuki H. Effects of protease inhibitor on reduction of surgical stress in esophagectomy. Am J Surg. 1999; 177:78-82. (Pubitemid 29089003)
15. Arakawa H, Iwakoshi H, Sakamoto K. Changes in interleukin-8 (IL-8) and neutrophil elastase in bronchoalveolar lavage (BAL) after surgery for esophageal cancer. Biotherapy. 1993;7:736-8. (in Japanese).
16. Reid PT, Donnnelly SC, MacGregor IR, Grant IS, Cameron E, Walker W, et al. Pulmonary endothelial permeability and circulating neutrophil-endothelial markers in patients undergoing esophagogastrectomy. Crit Care Med. 2000;28:3161-5.
17. Weiss SJ, Curnutte JT, Regiani S. Neutrophil-mediated solubilization of the subendothelial matrix: oxidative and nonoxidative mechanisms of proteolysis used by normal and chronic granulomatous disease phagocytes. J Immunol. 1986;136:636-41. (Pubitemid 16208151)
18. Doi K, Yamanaka K, Tsuneyoshi H. Effectiveness of Sivelestat sodium at the postoperative management against acute lung injury after type a acute aortic dissection. Prog Med. 2006;26:2264-6. (in Japanese).
19. Nishibe T, Kondo Y, Muto A, Dardik A, Ohara Y, Kainuma M, et al. Protective effect of sivelestat sodium (Elaspol®) on postoperative lung dysfunction in patients with type A acute aortic dissection: a pilot study. J Cardiovasc Surg (Torino). 2008;49: 627-31.
20. Furusawa T, Tsukioka K, Fukui D, Sakaguchi M, Seto T, Terasaki T, et al. The effects of a neutrophil elastase inhibitor on the postoperative respiratory failure of acute aortic dissection. Thorac Cardiovasc Surg. 2006;54:404-7. (Pubitemid 44519271)
21. Ryugo M, Sawa Y, Takano H, Matsumiya G, Iwai S, Ono M, et al. Effect of a polymorphonuclear elastase inhibitor (sivelestat sodium) on acute lung injury after cardiopulmonary bypass: findings of a double-blind randomized study. Surg Today. 2006; 36:321-6.
22. Minami T, Kashira K. Usefulness of perioperative sivelestat sodium in thoracic aorta replacement. Masui (Jpn J Anesthesi). 2006;55:977-82. (in Japanese).
23. Drug interview form 'Elaspol 100 for injection', revised in August 2005. 5th edn. p. 24.
24. Kadota Y, Nakura H, Ichikawa K, Mitaka C. Respiratory management patients after surgery for esophageal cancer in ICU. Rinshomasui (Jpn J Clin Anesth). 1997;21:1049-54. (in Japanese).
25. Takemura M, Osugi H, Ri E, Kaneko M, Tanaka Y, Fujiwara Y, et al. Trial of invasion reduction in esophageal cancer complete cure excision by elastase inhibitor. Rinshoto kenkyu (Jpn J Clin Exp Med). 2003;80:2289-92. (in Japanese).
26. Ono S, Tsujimoto H, Hiraki S, Takahata R, Kimura A, Kinoshita M, Ichikura T, Mochizuki H. Effects of neutrophil elastase inhibitor on progression of acute lung injury following esophagectomy. World J Surg. 2007;31:1996-2001. (Pubitemid 47415716)
27. Sasajima K, Futami R, Matsutani T, Nomura T, Makino H, Maruyama H, Miyashita M. Increases in soluble tumor necrosis factor receptors coincide with increases in interleukin-6 and proteinases after major surgery. Hepatogastroenterology. 2009; 56:1377-81.
28. Suda K, Kitagawa Y, Ozawa S, Miyasho T, Okamoto M, Saikawa Y, Ueda M, Yamada S, Tasaka S, Funakoshi Y, Hashimoto S, Yokota H, Maruyama I, Ishizaka A, Kitajima M. Neutrophil elastase inhibitor improves postoperative clinical courses after thoracic esophagectomy. Dis Esophagus. 2007;20:478-86. (Pubitemid 47617831)
29. Akamoto S, Okano K, Sano T, Yachida S, Izuishi K, Usuki H, Wakabayashi H, Suzuki Y. Neutrophil elastase inhibitor (sivelestat) preserves antitumor immunity and reduces the inflammatory mediators associated with major surgery. Surg Today. 2007;37:359-65. (Pubitemid 46684518)
30. Kawahara Y, Ninomiya I, Fujimura T, Funaki H, Nakagawara H, Takamura H, Oyama K, Tajima H, Fushida S, Inaba H, Kayahara M. Prospective randomized controlled study on the effects of perioperative administration of a neutrophil elastase inhibitor to patients undergoing video-assisted thoracoscopic surgery for thoracic esophageal cancer. Dis Esophagus. 2010;23:329-39.
31. Hoshi K, Yamamoto Y, Shibusawa M, Saito K, Agatsuma T, Kameyama Y, et al. The fluctuation of the circulatory blood volume during abdominal aortic aneurysm repair. Prog Med. 2008;28:1259-64. (in Japanese).